Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma
- 11 October 2020
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (1) , 41-57
Abstract
Estrogen is essential in maintaining various physiological features in women, and a decline in estrogen levels are known to give rise to numerous unfortunate symptoms associated with menopause. To alleviate these symptoms hormone replacement therapy with estrogen is often used, and has been shown to be fruitful in improving quality of life in women suffering from postmenopausal discomforts. An often forgotten condition associated with menopause is the optic nerve disorder, glaucoma. Thus, estrogen may also have an impact in maintaining the retinal ganglion cells (RGCs), which make up the optic nerve, thereby preventing glaucomatous neurodegeneration. This review aims to provide an overview of possible associations of estrogen and the glaucoma subtype, primary open-angle glaucoma (POAG), by evaluating the current literature through a PubMed-based literature search. Multiple in vitro and in vivo studies of RGC protection, as well as clinical and epidemiological data concerning the well-defined retinal neurodegenerative disorder POAG have been reviewed. Over all, deficiencies in retinal estrogen may potentially instigate RGC loss, visual disability, and eventual blindness. Estrogen replacement therapy may therefore be a beneficial future treatment. However, more studies are needed to confirm the relevance of estrogen in glaucoma prevention.Keywords
Funding Information
- Novo Nordisk Fonden (NNF18SA0034956)
This publication has 157 references indexed in Scilit:
- Molecular Basis for Involvement of CYP1B1 in MYOC Upregulation and Its Potential Implication in Glaucoma PathogenesisPLOS ONE, 2012
- Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: The Multi-Ethnic Study of AtherosclerosisAtherosclerosis, 2012
- Should Men and Women be Managed Differently in Glaucoma?Ophthalmology and Therapy, 2012
- Variability in short‐wavelength automated perimetry among peri‐ or postmenopausal women: a dependence on phyto‐oestrogen consumption?Acta Ophthalmologica, 2011
- Female reproductive factors and primary open-angle glaucoma in the Nurses’ Health StudyEye, 2011
- Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathyBrain, 2010
- Energy metabolism of the visual systemEye and Brain, 2010
- Estrogen actions on mitochondria—Physiological and pathological implicationsMolecular and Cellular Endocrinology, 2008
- Estimating the Rate of Progressive Visual Field Damage in Those with Open-Angle Glaucoma, from Cross-Sectional DataInvestigative Ophthalmology & Visual Science, 2008
- Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implicationsSteroids, 2007